ANALYST-UPGRADE filed Sep 1, 2026 at 07:59 ET
Rosenblatt initiated coverage on ABNB with a Buy rating and a $220 price target, representing 20.5% upside from the current $182.55. The firm has a 54% accuracy rate on 996 calls and an average return of 8.5%. Consensus is mixed: 28 Buy (72%), 20 Hold (26%), 2 Sell (3%) from 39 analysts. The mean target is $176.76, median $177, high $217, low $125. Rosenblatt's $220 target is above the consensus mean and high. Momentum is positive with 2 upgrades and 0 downgrades in the past 30 days. EPS revisions are trending higher: 18 up vs 5 down for the current quarter, 25 up vs 5 down for the current year. Insider Nathan Blecharczyk sold ~$2.5M on Aug 31, a bearish signal. Institutional activity is mixed: a new $20M position from Sculptor Capital LP and a 60.7% add from INTECH, but SRS trimmed 64.7% and Centiva trimmed 65.4%. Short interest is elevated at 65.8% of volume. The initiation from a mid-tier firm with a bullish PT above consensus is a modest positive signal, but insider selling and high short interest warrant caution.